Table 4.
Dabigatran | Warfarin | Clopidogrel | Aspirin | Control | |
---|---|---|---|---|---|
Transfused | 9 | 40 | 28 | 24 | 29 |
Not transfused | 27 | 32 | 44 | 48 | 115 |
OR (95% CI) | 1.3 (0.6–3.0) | 1.6 (1.3–1.9)* | 1.6 (1.2–2.3)* | 1.3 (1.0–1.6)* | 1.0 |
PRBC | 7 | 21 | 19 | 19 | 21 |
OR (95% CI) | 1.4 (0.5–3.8) | 1.3 (1.1–1.5)* | 1.5 (1.0–2.2)* | 1.3 (1.0–1.6)* | 1.0 |
FFP | 5 | 39 | 11 | 12 | 17 |
OR (95% CI) | 1.2 (0.4–3.5) | 1.9 (1.5–2.3)* | 1.2 (0.8–1.8) | 1.1 (0.9–1.5) | 1.0 |
PLT | 5 | 7 | 19 | 9 | 11 |
OR (95% CI) | 2.0 (0.6–6.4) | 1.1 (0.8–1.4) | 2.1 (1.4–3.3)* | 1.2 (0.9–1.7) | 1.0 |
Survived | 32 | 62 | 68 | 66 | 132 |
Died | 4 | 10 | 4 | 6 | 12 |
OR (95% CI) | 1.5 (0.4–5.9) | 1.2 (0.9–1.5) | 0.8 (0.4–1.5) | 1.0 (0.7–1.5) | 1.0 |
CI = confidence interval; FFP = fresh frozen plasma; OR = odds ratio; PLT = platelets; PRBC = packed red blood cells.
Statistically significant (p < 0.05).